63 related articles for article (PubMed ID: 161321)
21. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
Salehi N; Lichtenstein M; Pojer PM
J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
[TBL] [Abstract][Full Text] [Related]
22. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
Kato M
J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
[TBL] [Abstract][Full Text] [Related]
23. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
Rao SA; Knobel J; Collier BD; Isitman AT
J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting the labeling efficiency and stability of technetium-99m-labeled glucoheptonate.
Zbrzeznj DJ; Khan RA
Am J Hosp Pharm; 1981 Oct; 38(10):1499-502. PubMed ID: 7294045
[TBL] [Abstract][Full Text] [Related]
25. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
[TBL] [Abstract][Full Text] [Related]
26. Testing different storage conditions for (99m)Tc-MAG3 kit: can hot fractioning reduce the cost per unit dose?
Kiratli PO; Salanci BV
J Nucl Med Technol; 2003 Jun; 31(2):74-5. PubMed ID: 12777456
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents.
Kelbaek H; Fogh J
J Nucl Med; 1985 Jan; 26(1):68-71. PubMed ID: 3965654
[TBL] [Abstract][Full Text] [Related]
28. Use of a 99mTc labeled anti-TNFalpha monoclonal antibody in Crohn's disease: in vitro and in vivo studies.
D'Alessandria C; Malviya G; Viscido A; Aratari A; Maccioni F; Amato A; Scopinaro F; Caprilli R; Signore A
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):334-42. PubMed ID: 17464276
[TBL] [Abstract][Full Text] [Related]
29. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
30. Chemotaxis, viability, and labeling stability of leukocytes labeled with (99m)Tc-exametazime stabilized with methylene blue.
Roca M; Iglesias F; García V; Armero F; Díaz MC
J Nucl Med; 2001 Mar; 42(3):505-8. PubMed ID: 11337530
[TBL] [Abstract][Full Text] [Related]
31. Radiolabeling of affinity-purified goat anti-carcinoembryonic antigen immunoglobulin G with technetium-99m.
Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
Cancer Res; 1980 Aug; 40(8 Pt 2):3043-5. PubMed ID: 7397698
[TBL] [Abstract][Full Text] [Related]
32. Technical parameters of in vivo red blood cell labeling with Technetium-99m.
Zimmer AM; Pavel DG; Karesh SM
Nuklearmedizin; 1979 Dec; 18(5):241-5. PubMed ID: 547251
[TBL] [Abstract][Full Text] [Related]
33. Differential registration of two types of radionuclides on macroautoradiograms for studying coronary circulation: concise communication.
Tomoike H; Ogata I; Maruoka Y; Sakai K; Kurozumi T; Nakamura M
J Nucl Med; 1983 Aug; 24(8):693-9. PubMed ID: 6308190
[TBL] [Abstract][Full Text] [Related]
34. Labeling of red blood cells with Tc-99m after oral administration of SnCl2: concise communication.
Patel MC; Parab PB; Samuel AM; Ganatra RD
J Nucl Med; 1979 Aug; 20(8):877-81. PubMed ID: 541736
[TBL] [Abstract][Full Text] [Related]
35. Some chemical aspects of labeling human fibrinogen with 99m-technetium.
Kirstein M; Fridrich R; Seiler H
Thromb Res; 1982 Nov; 28(3):351-60. PubMed ID: 6294903
[TBL] [Abstract][Full Text] [Related]
36. [Production of ready-to-use technetium (Tc)-99m and Tc99m-labeled radiopharmaceuticals].
Angelberger P
Strahlentherapie Sonderb; 1975; 74():457-60. PubMed ID: 53914
[No Abstract] [Full Text] [Related]
37. [Thrombin-plasmin system of the body, its biological role and the significance of its disorders in pathology].
Monastyrskiĭ VA
Probl Gematol Pereliv Krovi; 1979 Jul; 24(7):19-23. PubMed ID: 157484
[No Abstract] [Full Text] [Related]
38. An ultrafiltration technique for labeling red blood cells with Tc-99m.
Hendershott LR; Gatson RC; Ordway FS; Ahmad M
Eur J Nucl Med; 1979 Jun; 4(3):187-90. PubMed ID: 499240
[TBL] [Abstract][Full Text] [Related]
39. Tc-99m-labeled polystyrene and cellulose macromolecules: agents for gastrointestinal scintigraphy.
Theodorakis MC; Groutas WC; Whitlock TW; Tran K
J Nucl Med; 1982 Aug; 23(8):693-7. PubMed ID: 7108613
[TBL] [Abstract][Full Text] [Related]
40. Labeling plasmin with technetium-99m for scintigraphic localization of thrombi.
Persson BR; Darte L
Int J Appl Radiat Isot; 1977; 28(1-2):97-104. PubMed ID: 140151
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
